,ChemicalName,ChemicalID,CasRN,GeneSymbol,GeneID,GeneForms,Organism,OrganismID,Interaction,InteractionActions,PubMedIDs,Canonical SMILES
0,"1,2,5,6-dibenzanthracene",C026486,53-70-3,C1QB,713,mRNA,Mus musculus,10090.0,"1,2,5,6-dibenzanthracene results in decreased expression of C1QB mRNA",decreases^expression,26377693,[{5889: 'C1=CC=C2C(=C1)C=CC3=CC4=C(C=CC5=CC=CC=C54)C=C32'}]
1,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane",C517232,,C1QB,713,mRNA,Mus musculus,10090.0,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of C1QB mRNA]",decreases^reaction|increases^expression,33848595,[{18728: 'C1CC(C(CC1C(CBr)Br)Br)Br'}]
2,"1,2-Dimethylhydrazine",D019813,540-73-8,C1QB,713,mRNA,Mus musculus,10090.0,"1,2-Dimethylhydrazine results in increased expression of C1QB mRNA",increases^expression,22206623,[{1322: 'CNNC'}]
3,"1,2-Dimethylhydrazine",D019813,540-73-8,C1QB,713,mRNA,Mus musculus,10090.0,"Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of C1QB mRNA]",decreases^reaction|increases^expression,22206623,
4,"1,2-dithiol-3-thione",C049325,,C1QB,713,mRNA,Rattus norvegicus,10116.0,"1,2-dithiol-3-thione results in decreased expression of C1QB mRNA",decreases^expression,19162173,[{68296: 'C1=CSSC1=S'}]
5,1-Naphthylisothiocyanate,D015058,551-06-4,C1QB,713,mRNA,Homo sapiens,9606.0,[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C1QB mRNA,affects^cotreatment|affects^expression,27344345,[{11080: 'C1=CC=C2C(=C1)C=CC=C2N=C=S'}]
6,1-Naphthylisothiocyanate,D015058,551-06-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,1-Naphthylisothiocyanate results in increased expression of C1QB mRNA,increases^expression,25380136,
7,"2,2',4,4'-tetrabromodiphenyl ether",C511295,,C1QB,713,mRNA,Rattus norvegicus,10116.0,"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of C1QB mRNA",decreases^expression,31826744,[{95170: 'C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2)Br)Br'}]
8,"2,2,5,7,8-pentamethyl-1-hydroxychroman",C029141,950-99-2,C1QB,713,mRNA,Rattus norvegicus,10116.0,"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of C1QB mRNA",decreases^expression,21920950,[{99479: 'CC1=C(C2=C(CCC(O2)(C)C)C(=C1O)C)C'}]
9,"2,3',4,4',5-pentachlorobiphenyl",C070055,,C1QB,713,mRNA,Mus musculus,10090.0,"2,3',4,4',5-pentachlorobiphenyl results in increased expression of C1QB mRNA",increases^expression,31388691,[{35823: 'C1=CC(=C(C=C1C2=CC(=C(C=C2Cl)Cl)Cl)Cl)Cl'}]
10,"3,4,5,3',4'-pentachlorobiphenyl",C023035,57465-28-8,C1QB,713,mRNA,Danio rerio,7955.0,"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of C1QB mRNA",decreases^expression,28973690,[{63090: 'C1=CC(=C(C=C1C2=CC(=C(C(=C2)Cl)Cl)Cl)Cl)Cl'}]
11,"3,4,5,3',4'-pentachlorobiphenyl",C023035,57465-28-8,C1QB,713,mRNA,Homo sapiens,9606.0,"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of C1QB mRNA",decreases^expression,23146750,
12,3-dinitrobenzene,C017906,99-65-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,3-dinitrobenzene results in increased expression of C1QB mRNA,increases^expression,21983209,[{7452: 'C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-]'}]
13,"4,4'-diaminodiphenylmethane",C009505,101-77-9,C1QB,713,mRNA,Mus musculus,10090.0,"4,4'-diaminodiphenylmethane results in decreased expression of C1QB mRNA",decreases^expression,18648102,[{7577: 'C1=CC(=CC=C1CC2=CC=C(C=C2)N)N'}]
14,"9,10-Dimethyl-1,2-benzanthracene",D015127,57-97-6,C1QB,713,mRNA,Mus musculus,10090.0,"9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QB mRNA",affects^expression,21785161,[{6001: 'CC1=C2C=CC3=CC=CC=C3C2=C(C4=CC=CC=C14)C'}]
15,A-83-01,C507011,,C1QB,713,mRNA,Mus musculus,10090.0,[IGF1 protein co-treated with MM-589 co-treated with A-83-01 co-treated with PTC-209] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,31023824,[{16218924: 'CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5'}]
16,acetamide,C030686,60-35-5,C1QB,713,mRNA,Rattus norvegicus,10116.0,acetamide results in increased expression of C1QB mRNA,increases^expression,31881176,[{178: 'CC(=O)N'}]
17,Acetaminophen,D000082,103-90-2,C1QB,713,mRNA,Mus musculus,10090.0,Acetaminophen affects the expression of C1QB mRNA,affects^expression,17562736,[{1983: 'CC(=O)NC1=CC=C(C=C1)O'}]
18,Aflatoxin B1,D016604,1162-65-8,C1QB,713,mRNA,Rattus norvegicus,10116.0,Aflatoxin B1 results in decreased expression of C1QB mRNA,decreases^expression,33354967,[{186907: 'COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1'}]
19,Amitrole,D000640,61-82-5,C1QB,713,mRNA,Rattus norvegicus,10116.0,Amitrole results in increased expression of C1QB mRNA,increases^expression,30047161,[{1639: 'C1=NNC(=N1)N'}]
20,Ammonium Chloride,D000643,12125-02-9,C1QB,713,mRNA,Rattus norvegicus,10116.0,Ammonium Chloride affects the expression of C1QB mRNA,affects^expression,16483693,[{25517: '[NH4+].[Cl-]'}]
21,"amphotericin B, deoxycholate drug combination",C059765,87687-70-5,C1QB,713,mRNA,Mus musculus,10090.0,"amphotericin B, deoxycholate drug combination results in increased expression of C1QB mRNA",increases^expression,22863853,[{23668620: 'C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O.C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+]'}]
22,"Antigens, Dermatophagoides",D039741,,C1QB,713,mRNA,Mus musculus,10090.0,"[Particulate Matter co-treated with Antigens, Dermatophagoides] results in increased expression of C1QB mRNA",affects^cotreatment|increases^expression,34051097,
23,Antirheumatic Agents,D018501,,C1QB,713,mRNA,Homo sapiens,9606.0,Antirheumatic Agents results in decreased expression of C1QB mRNA,decreases^expression,24449571,
24,Arbutin,D001104,497-76-7,C1QB,713,mRNA,Homo sapiens,9606.0,Arbutin results in decreased expression of C1QB mRNA,decreases^expression,17103032,[{440936: 'C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O'}]
25,Arsenic Trioxide,D000077237,1327-53-3,C1QB,713,mRNA,Homo sapiens,9606.0,Arsenic Trioxide results in increased expression of C1QB mRNA,increases^expression,19128835,[{14888: '[O-2].[O-2].[O-2].[As+3].[As+3]'}]
26,Aza Compounds,D001372,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Aza Compounds results in decreased expression of C1QB mRNA,decreases^expression,20521778,
27,Aza Compounds,D001372,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Aza Compounds results in increased expression of C1QB mRNA,increases^expression,20521778,
28,AZM551248,C547126,,C1QB,713,mRNA,Canis lupus familiaris,9615.0,AZM551248 results in increased expression of C1QB mRNA,increases^expression,22323515,
29,Azoxymethane,D001397,25843-45-2,C1QB,713,mRNA,Mus musculus,10090.0,[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,29950665,[{33184: 'CN=[N+](C)[O-]'}]
30,Benzo(a)pyrene,D001564,50-32-8,C1QB,713,promoter,Homo sapiens,9606.0,Benzo(a)pyrene affects the methylation of C1QB promoter,affects^methylation,27901495,[{2336: 'C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3'}]
31,Benzo(a)pyrene,D001564,50-32-8,C1QB,713,3' UTR,Homo sapiens,9606.0,Benzo(a)pyrene results in increased methylation of C1QB 3' UTR,increases^methylation,27901495,
32,Benzo(a)pyrene,D001564,50-32-8,C1QB,713,mRNA,Mus musculus,10090.0,AHR protein affects the reaction [Benzo(a)pyrene affects the expression of C1QB mRNA],affects^expression|affects^reaction,22228805,
33,Benzo(a)pyrene,D001564,50-32-8,C1QB,713,mRNA,Mus musculus,10090.0,Benzo(a)pyrene results in decreased expression of C1QB mRNA,decreases^expression,19770486,
34,Benzo(a)pyrene,D001564,50-32-8,C1QB,713,mRNA,Mus musculus,10090.0,Benzo(a)pyrene results in increased expression of C1QB mRNA,increases^expression,22228805,
35,benzyloxycarbonylleucyl-leucyl-leucine aldehyde,C072553,,C1QB,713,mRNA,Mus musculus,10090.0,benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of C1QB mRNA,decreases^expression,25566086,[{462382: 'CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1'}]
36,benzyloxycarbonylleucyl-leucyl-leucine aldehyde,C072553,,C1QB,713,mRNA,Mus musculus,10090.0,MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of C1QB mRNA],affects^reaction|decreases^expression,25566086,
37,Bexarotene,D000077610,,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Bexarotene co-treated with Tamoxifen] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,17630414,[{82146: 'CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C'}]
38,Bexarotene,D000077610,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Bexarotene results in increased expression of C1QB mRNA,increases^expression,16648578,
39,bis(4-hydroxyphenyl)sulfone,C543008,80-09-1,C1QB,713,mRNA,Mus musculus,10090.0,bis(4-hydroxyphenyl)sulfone results in increased expression of C1QB mRNA,increases^expression,30951980,[{6626: 'C1=CC(=CC=C1O)S(=O)(=O)C2=CC=C(C=C2)O'}]
40,bisphenol A,C006780,80-05-7,C1QB,713,mRNA,Danio rerio,7955.0,bisphenol A affects the expression of C1QB mRNA,affects^expression,21786754,[{6623: 'CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O'}]
41,bisphenol A,C006780,80-05-7,C1QB,713,mRNA,Mus musculus,10090.0,bisphenol A results in decreased expression of C1QB mRNA,decreases^expression,25594700,
42,bisphenol A,C006780,80-05-7,C1QB,713,promoter,Mus musculus,10090.0,bisphenol A results in decreased methylation of C1QB promoter,decreases^methylation,27312807,
43,bisphenol A,C006780,80-05-7,C1QB,713,mRNA,Pimephales promelas,90988.0,bisphenol A affects the expression of C1QB mRNA,affects^expression,21786754,
44,bisphenol A,C006780,80-05-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,bisphenol A affects the expression of C1QB mRNA,affects^expression,32145629,
45,bisphenol A,C006780,80-05-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,bisphenol A results in decreased expression of C1QB mRNA,decreases^expression,25181051,
46,bisphenol A,C006780,80-05-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,bisphenol A results in increased expression of C1QB mRNA,increases^expression,30816183|32528016,
47,bisphenol F,C000611646,,C1QB,713,mRNA,Mus musculus,10090.0,bisphenol F results in increased expression of C1QB mRNA,increases^expression,30951980,[{12111: 'C1=CC(=CC=C1CC2=CC=C(C=C2)O)O'}]
48,Bleomycin,D001761,11056-06-7,C1QB,713,mRNA,Mus musculus,10090.0,Bleomycin results in increased expression of C1QB mRNA,increases^expression,26345256,"[{5360373: 'CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O'}, {5460769: 'CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O'}, {84068: 'CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O'}, {456190: 'CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O'}, {155903698: 'CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@@H]3[C@@H]([C@@H]([C@H]([C@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@@H](C)[C@@H]([C@@H](C)C(=O)N[C@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O'}]"
49,Blood Glucose,D001786,,C1QB,713,mRNA,Mus musculus,10090.0,"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of C1QB mRNA",affects^cotreatment|increases^expression,19640911,
50,Buspirone,D002065,36505-84-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,Buspirone results in decreased expression of C1QB mRNA,decreases^expression,24136188,[{2477: 'C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4'}]
51,Cadmium,D002104,7440-43-9,C1QB,713,protein,Homo sapiens,9606.0,C1QB protein binds to Cadmium,affects^binding,23896426,[{23973: '[Cd]'}]
52,Cadmium Chloride,D019256,10108-64-2,C1QB,713,mRNA,Rattus norvegicus,10116.0,Cadmium Chloride results in decreased expression of C1QB mRNA,decreases^expression,25993096|33453195,[{24947: 'Cl[Cd]Cl'}]
53,Cadmium Chloride,D019256,10108-64-2,C1QB,713,promoter,Rattus norvegicus,10116.0,Cadmium Chloride results in decreased methylation of C1QB promoter,decreases^methylation,22457795,
54,Calcitriol,D002117,32222-06-3,C1QB,713,mRNA,Homo sapiens,9606.0,Calcitriol results in decreased expression of C1QB mRNA,decreases^expression,26485663,[{5280453: 'C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C'}]
55,Captan,D002215,133-06-2,C1QB,713,mRNA,Mus musculus,10090.0,Captan results in decreased expression of C1QB mRNA,decreases^expression,31558096,[{8606: 'C1C=CCC2C1C(=O)N(C2=O)SC(Cl)(Cl)Cl'}]
56,Carbon Tetrachloride,D002251,56-23-5,C1QB,713,mRNA,Mus musculus,10090.0,Carbon Tetrachloride results in increased expression of C1QB mRNA,increases^expression,27339419|29987408|31919559,[{5943: 'C(Cl)(Cl)(Cl)Cl'}]
57,carbonyl sulfide,C010063,463-58-1,C1QB,713,mRNA,Rattus norvegicus,10116.0,carbonyl sulfide results in increased expression of C1QB mRNA,increases^expression,19395590,[{10039: 'C(=O)=S'}]
58,Cellulose,D002482,9004-34-6,C1QB,713,mRNA,Mus musculus,10090.0,[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,36331819,[{16211032: 'C(C1[C@H](C(C(C(O1)O)O)O)O[C@H]2C(C(C(C(O2)CO)O)O)O)O'}]
59,Cholic Acids,D002793,,C1QB,713,mRNA,Homo sapiens,9606.0,[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of C1QB mRNA,affects^cotreatment|affects^expression,27344345,
60,Cholic Acids,D002793,,C1QB,713,mRNA,Homo sapiens,9606.0,[Cyclosporine co-treated with Cholic Acids] affects the expression of C1QB mRNA,affects^cotreatment|affects^expression,27344345,
61,Choline,D002794,62-49-7,C1QB,713,mRNA,Mus musculus,10090.0,[Dietary Fats co-treated with Choline deficiency] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,29246445,[{305: 'C[N+](C)(C)CCO'}]
62,Choline,D002794,62-49-7,C1QB,713,mRNA,Mus musculus,10090.0,[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,20938992,
63,Choline,D002794,62-49-7,C1QB,713,mRNA,Mus musculus,10090.0,PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of C1QB mRNA],affects^cotreatment|decreases^reaction|increases^expression,29246445,
64,CI 1044,C418118,,C1QB,713,mRNA,Rattus norvegicus,10116.0,CI 1044 results in increased expression of C1QB mRNA,increases^expression,17569694,[{9843744: 'C1CN2C(=O)[C@@H](N=C(C3=CC(=CC1=C32)N)C4=CC=CC=C4)NC(=O)C5=CN=CC=C5'}]
65,Clofibrate,D002994,637-07-0,C1QB,713,mRNA,Mus musculus,10090.0,Clofibrate results in decreased expression of C1QB mRNA,decreases^expression,23811191,[{2796: 'CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl'}]
66,Cuprizone,D003471,370-81-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,Cuprizone results in increased expression of C1QB mRNA,increases^expression,27523638,[{9723: 'C1CCC(=NNC(=O)C(=O)NN=C2CCCCC2)CC1'}]
67,Curcumin,D003474,458-37-7,C1QB,713,mRNA,Mus musculus,10090.0,Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of C1QB mRNA],decreases^reaction|increases^expression,18200517,[{969516: 'COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O'}]
68,cyanoginosin LR,C057862,,C1QB,713,mRNA,Aquarana catesbeiana,8400.0,cyanoginosin LR results in increased expression of C1QB mRNA,increases^expression,34863901,[{445434: 'C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)C)CCCN=C(N)N)/C=C/C(=C/[C@H](C)[C@H](CC2=CC=CC=C2)OC)/C'}]
69,cyclonite,C009160,121-82-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,cyclonite results in increased expression of C1QB mRNA,increases^expression,25559034,[{8490: 'C1N(CN(CN1[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-]'}]
70,Cyclosporine,D016572,59865-13-3,C1QB,713,mRNA,Homo sapiens,9606.0,[Cyclosporine co-treated with Cholic Acids] affects the expression of C1QB mRNA,affects^cotreatment|affects^expression,27344345,"[{5284373: 'CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}, {6435893: 'CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}, {5280754: 'CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}, {24883466: 'CC[C@@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}, {5497195: 'CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@H]([C@H](C)C/C=C\\C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}, {25246316: 'CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)NC(C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}, {123134263: 'CC[C@@H]1C(=O)N(CC(=O)N([C@@H](C(=O)N[C@@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)NC(C(=O)N([C@@H](C(=O)N([C@@H](C(=O)N([C@@H](C(=O)N(C(C(=O)N1)C([C@@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}]"
71,Cyclosporine,D016572,59865-13-3,C1QB,713,mRNA,Rattus norvegicus,10116.0,Cyclosporine results in increased expression of C1QB mRNA,increases^expression,21865292,
72,cypermethrin,C017160,52315-07-8,C1QB,713,mRNA,Mus musculus,10090.0,cypermethrin results in increased expression of C1QB mRNA,increases^expression,35031408,[{2912: 'CC1(C(C1C(=O)OC(C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C'}]
73,decamethrin,C017180,52820-00-5,C1QB,713,mRNA,Mus musculus,10090.0,decamethrin results in increased expression of C1QB mRNA,increases^expression,37019170,[{40585: 'CC1([C@H]([C@H]1C(=O)O[C@H](C#N)C2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Br)Br)C'}]
74,Dextran Sulfate,D016264,9042-14-2,C1QB,713,mRNA,Mus musculus,10090.0,[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,29950665,
75,Diclofenac,D004008,15307-86-5,C1QB,713,mRNA,Mus musculus,10090.0,Diclofenac results in increased expression of C1QB mRNA,increases^expression,26934552,[{3033: 'C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl'}]
76,Dietary Fats,D004041,,C1QB,713,mRNA,Mus musculus,10090.0,[Dietary Fats co-treated with Choline deficiency] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,29246445,
77,Dietary Fats,D004041,,C1QB,713,mRNA,Mus musculus,10090.0,Dietary Fats results in decreased expression of C1QB mRNA,decreases^expression,18042831,
78,Dietary Fats,D004041,,C1QB,713,mRNA,Mus musculus,10090.0,Dietary Fats results in increased expression of C1QB mRNA,increases^expression,22609946,
79,Dietary Fats,D004041,,C1QB,713,mRNA,Mus musculus,10090.0,PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of C1QB mRNA],affects^cotreatment|decreases^reaction|increases^expression,29246445,
80,Diethylnitrosamine,D004052,55-18-5,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,28943392,[{5921: 'CCN(CC)N=O'}]
81,diisodecyl phthalate,C042080,26761-40-0,C1QB,713,mRNA,Mus musculus,10090.0,diisodecyl phthalate results in increased expression of C1QB mRNA,increases^expression,25270620,[{33599: 'CC(C)CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C'}]
82,Dimethylnitrosamine,D004128,62-75-9,C1QB,713,mRNA,Rattus norvegicus,10116.0,Dimethylnitrosamine results in increased expression of C1QB mRNA,increases^expression,25380136,[{6124: 'CN(C)N=O'}]
83,Diuron,D004237,330-54-1,C1QB,713,mRNA,Rattus norvegicus,10116.0,Diuron results in decreased expression of C1QB mRNA,decreases^expression,25152437,[{3120: 'CN(C)C(=O)NC1=CC(=C(C=C1)Cl)Cl'}]
84,doramapimod,C452139,,C1QB,713,mRNA,Mus musculus,10090.0,doramapimod results in decreased expression of C1QB mRNA,decreases^expression,21328587,[{156422: 'CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5'}]
85,Doxorubicin,D004317,23214-92-8,C1QB,713,mRNA,Rattus norvegicus,10116.0,Doxorubicin results in increased expression of C1QB mRNA,increases^expression,32289291,[{31703: 'C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O'}]
86,Endosulfan,D004726,115-29-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,Endosulfan results in decreased expression of C1QB mRNA,decreases^expression,29391264,[{3224: 'C1C2C(COS(=O)O1)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl'}]
87,Estradiol,D004958,50-28-2,C1QB,713,mRNA,Mus musculus,10090.0,Estradiol affects the expression of C1QB mRNA,affects^expression,15598610,[{5757: 'C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O'}]
88,Estradiol,D004958,50-28-2,C1QB,713,mRNA,Mus musculus,10090.0,Estradiol results in increased expression of C1QB mRNA,increases^expression,19484750,
89,Estradiol,D004958,50-28-2,C1QB,713,mRNA,Rattus norvegicus,10116.0,[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,32741896,
90,estradiol 3-benzoate,C074283,50-50-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,32741896,[{222757: 'C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5'}]
91,Ethanol,D000431,64-17-5,C1QB,713,mRNA,Mus musculus,10090.0,Ethanol results in increased expression of C1QB mRNA,increases^expression,30319688,[{702: 'CCO'}]
92,Ethanol,D000431,64-17-5,C1QB,713,mRNA,Rattus norvegicus,10116.0,Ethanol results in decreased expression of C1QB mRNA,decreases^expression,17920746,
93,Ethinyl Estradiol,D004997,57-63-6,C1QB,713,mRNA,Mus musculus,10090.0,[Ethinyl Estradiol co-treated with IL1B protein] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,12072388,[{5991: 'C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O'}]
94,Ethinyl Estradiol,D004997,57-63-6,C1QB,713,mRNA,Mus musculus,10090.0,Ethinyl Estradiol results in increased expression of C1QB mRNA,increases^expression,12072388,
95,Ethinyl Estradiol,D004997,57-63-6,C1QB,713,mRNA,Mus musculus,10090.0,[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,17942748,
96,Ethinyl Estradiol,D004997,57-63-6,C1QB,713,mRNA,Rattus norvegicus,10116.0,Ethinyl Estradiol results in increased expression of C1QB mRNA,increases^expression,15834898,
97,fipronil,C082360,120068-37-3,C1QB,713,mRNA,Danio rerio,7955.0,fipronil results in decreased expression of C1QB mRNA,decreases^expression,32977147,[{3352: 'C1=C(C=C(C(=C1Cl)N2C(=C(C(=N2)C#N)S(=O)C(F)(F)F)N)Cl)C(F)(F)F'}]
98,flusilazole,C061365,85509-19-9,C1QB,713,mRNA,Danio rerio,7955.0,flusilazole results in decreased expression of C1QB mRNA,decreases^expression,22382673,[{73675: 'C[Si](CN1C=NC=N1)(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F'}]
99,flusilazole,C061365,85509-19-9,C1QB,713,mRNA,Danio rerio,7955.0,flusilazole results in increased expression of C1QB mRNA,increases^expression,22382673,
100,Flutamide,D005485,13311-84-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,Flutamide results in decreased expression of C1QB mRNA,decreases^expression,24136188,[{3397: 'CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F'}]
101,Folic Acid,D005492,59-30-3,C1QB,713,mRNA,Mus musculus,10090.0,"Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of C1QB mRNA]",decreases^reaction|increases^expression,22206623,[{135398658: 'C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N'}]
102,Folic Acid,D005492,59-30-3,C1QB,713,mRNA,Mus musculus,10090.0,[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,20938992,
103,folpet,C005020,133-07-3,C1QB,713,mRNA,Mus musculus,10090.0,folpet results in decreased expression of C1QB mRNA,decreases^expression,31558096,[{8607: 'C1=CC=C2C(=C1)C(=O)N(C2=O)SC(Cl)(Cl)Cl'}]
104,fumonisin B1,C056933,116355-83-0,C1QB,713,mRNA,Mus musculus,10090.0,fumonisin B1 results in increased expression of C1QB mRNA,increases^expression,16221962,"[{2733487: 'CCCC[C@@H](C)[C@H]([C@H](C[C@@H](C)C[C@@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O'}, {3431: 'CCCCC(C)C(C(CC(C)CC(CCCCC(CC(C(C)N)O)O)O)OC(=O)CC(CC(=O)O)C(=O)O)OC(=O)CC(CC(=O)O)C(=O)O'}, {62314: 'CCCC[C@H](C)[C@H]([C@@H](C[C@H](C)C[C@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O'}, {14077784: 'CCCC[C@@H](C)[C@H]([C@H](C[C@@H](C)C[C@@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O'}, {133562683: 'CCCC[C@@H](C)[C@H]([C@H](C[C@H](C)C[C@@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O'}, {73707380: 'CCCC[C@@H](C)[C@H]([C@H](CC(C)C[C@@H](CCCC[C@H](C[C@@H]([C@H](C)N)O)O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O'}, {139593369: 'CCCC[C@H](C)[C@@H]([C@@H](C[C@H](C)C[C@H](CCCC[C@@H](C[C@H]([C@@H](C)N)O)O)O)OC(=O)C[C@@H](CC(=O)O)C(=O)O)OC(=O)C[C@H](CC(=O)O)C(=O)O'}]"
105,Gentamicins,D005839,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Gentamicins results in increased expression of C1QB mRNA,increases^expression,21081137,[{3467: 'CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC'}]
106,Ginkgo biloba extract,C063170,,C1QB,713,promoter,Mus musculus,10090.0,Ginkgo biloba extract results in decreased methylation of C1QB promoter,decreases^methylation,31278416,
107,Ginkgo biloba extract,C063170,,C1QB,713,mRNA,Mus musculus,10090.0,Ginkgo biloba extract results in increased expression of C1QB mRNA,increases^expression,31278416,
108,Hexachlorobenzene,D006581,118-74-1,C1QB,713,mRNA,Rattus norvegicus,10116.0,Hexachlorobenzene results in increased expression of C1QB mRNA,increases^expression,15159207,[{8370: 'C1(=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl'}]
109,IMM 125,C082770,,C1QB,713,mRNA,Rattus norvegicus,10116.0,IMM 125 results in increased expression of C1QB mRNA,increases^expression,21081137,[{129632314: 'CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)COCCO)C)CC(C)C)C)C(C)C)CC(C)C)C)C'}]
110,Indoles,D007211,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Indoles results in decreased expression of C1QB mRNA,decreases^expression,20521778,[{139191468: 'C1=CC=C2C(=C1)C=C(N2)CC3=CC=C(C=C3)C(F)(F)F.C1=CC=C2C(=C1)C=C(N2)CC3=CC=C(C=C3)C(F)(F)F'}]
111,Indoles,D007211,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Indoles results in increased expression of C1QB mRNA,increases^expression,20521778,
112,Ionomycin,D015759,56092-81-0,C1QB,713,mRNA,Oryctolagus cuniculus,9986.0,[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,25613284,[{6912226: 'C[C@H](CCC(=O)O)C[C@H](C)C[C@H](C)C(=O)/C=C(/[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@H]([C@@H](C)[C@H](C[C@@H]1CC[C@@](O1)(C)[C@H]2CC[C@@](O2)(C)[C@@H](C)O)O)O)\\O'}]
113,Kainic Acid,D007608,487-79-6,C1QB,713,mRNA,Mus musculus,10090.0,Kainic Acid results in increased expression of C1QB mRNA,increases^expression,17997037,[{10255: 'CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O'}]
114,Ketamine,D007649,6740-88-1,C1QB,713,mRNA,Rattus norvegicus,10116.0,Ketamine results in increased expression of C1QB mRNA,increases^expression,20080153,[{3821: 'CNC1(CCCCC1=O)C2=CC=CC=C2Cl'}]
115,"lipopolysaccharide, E coli O55-B5",C482199,,C1QB,713,mRNA,Chloris chloris,37601.0,"lipopolysaccharide, E coli O55-B5 results in decreased expression of C1QB mRNA",decreases^expression,24972896,
116,"lipopolysaccharide, E coli O55-B5",C482199,,C1QB,713,mRNA,Mus musculus,10090.0,"lipopolysaccharide, E coli O55-B5 results in increased expression of C1QB mRNA",increases^expression,23306164,
117,Lipopolysaccharides,D008070,,C1QB,713,mRNA,Mus musculus,10090.0,Lipopolysaccharides results in increased expression of C1QB mRNA,increases^expression,27339419,
118,Medroxyprogesterone Acetate,D017258,71-58-9,C1QB,713,mRNA,Homo sapiens,9606.0,Medroxyprogesterone Acetate results in increased expression of C1QB mRNA,increases^expression,20843944,[{6279: 'C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C'}]
119,Methimazole,D008713,60-56-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,Methimazole results in increased expression of C1QB mRNA,increases^expression,30047161,[{1349907: 'CN1C=CNC1=S'}]
120,Methionine,D008715,63-68-3,C1QB,713,mRNA,Mus musculus,10090.0,[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,20938992,"[{6137: 'CSCC[C@@H](C(=O)O)N'}, {876: 'CSCCC(C(=O)O)N'}, {84815: 'CSCC[C@H](C(=O)O)N'}]"
121,Methotrexate,D008727,59-05-2,C1QB,713,mRNA,Homo sapiens,9606.0,Methotrexate results in decreased expression of C1QB mRNA,decreases^expression,17400583,[{126941: 'CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O'}]
122,Methotrexate,D008727,59-05-2,C1QB,713,mRNA,Mus musculus,10090.0,Methotrexate affects the expression of C1QB mRNA,affects^expression,18502557,
123,methylmercury cysteine,C030589,12628-19-2,C1QB,713,mRNA,Mus musculus,10090.0,methylmercury cysteine results in decreased expression of C1QB mRNA,decreases^expression,19465457,[{151723: 'C[Hg+].C([C@@H](C(=O)[O-])N)S'}]
124,Methylnitronitrosoguanidine,D008769,70-25-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,Methylnitronitrosoguanidine results in increased expression of C1QB mRNA,increases^expression,15120970,[{135436526: 'CN(C(=N)N[N+](=O)[O-])N=O'}]
125,MM-589,C000621807,,C1QB,713,mRNA,Mus musculus,10090.0,[IGF1 protein co-treated with MM-589 co-treated with A-83-01 co-treated with PTC-209] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,31023824,[{129010138: 'CC[C@H]1C(=O)N[C@@H](C(=O)NCC[C@@](C(=O)N[C@H](C(=O)N1)CCCNC(=NC)N)(C)NC(=O)C(C)C)C2=CC=CC=C2'}]
126,monomethylpropion,C047806,5650-44-2,C1QB,713,mRNA,Homo sapiens,9606.0,monomethylpropion results in increased expression of C1QB mRNA,increases^expression,22303338,[{1576: 'CC(C(=O)C1=CC=CC=C1)NC'}]
127,"Nanotubes, Carbon",D037742,,C1QB,713,mRNA,Mus musculus,10090.0,"Nanotubes, Carbon analog results in increased expression of C1QB mRNA",increases^expression,25554681,[{297: 'C'}]
128,"Nanotubes, Carbon",D037742,,C1QB,713,mRNA,Mus musculus,10090.0,"Nanotubes, Carbon results in increased expression of C1QB mRNA",increases^expression,25554681,
129,n-butoxyethanol,C017096,111-76-2,C1QB,713,mRNA,Mus musculus,10090.0,n-butoxyethanol results in increased expression of C1QB mRNA,increases^expression,19812364,[{8133: 'CCCCOCCO'}]
130,Nickel,D009532,7440-02-0,C1QB,713,protein,Homo sapiens,9606.0,C1QB protein binds to Nickel,affects^binding,23896426,[{935: '[Ni]'}]
131,Nickel,D009532,7440-02-0,C1QB,713,mRNA,Homo sapiens,9606.0,Nickel results in increased expression of C1QB mRNA,increases^expression,24768652|25583101,
132,nickel sulfate,C029938,7786-81-4,C1QB,713,mRNA,Homo sapiens,9606.0,nickel sulfate results in decreased expression of C1QB mRNA,decreases^expression,16780908,[{24586: '[O-]S(=O)(=O)[O-].[Ni+2]'}]
133,nimesulide,C012655,51803-78-2,C1QB,713,mRNA,Homo sapiens,9606.0,nimesulide inhibits the reaction [PTGS2 results in increased expression of C1QB mRNA],decreases^reaction|increases^expression,11810182,[{4495: 'CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2'}]
134,nimesulide,C012655,51803-78-2,C1QB,713,mRNA,Rattus norvegicus,10116.0,nimesulide results in decreased expression of C1QB mRNA,decreases^expression,24136188,
135,nitrofen,C007350,,C1QB,713,mRNA,Rattus norvegicus,10116.0,nitrofen results in increased expression of C1QB mRNA,increases^expression,33484710,[{15787: 'C1=CC(=CC=C1[N+](=O)[O-])OC2=C(C=C(C=C2)Cl)Cl'}]
136,"N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride",C434926,,C1QB,713,mRNA,Mus musculus,10090.0,"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of C1QB mRNA",affects^cotreatment|increases^expression,19640911,[{4858: 'CN(C)CC(=O)NC1=CC2=C(C=C1)NC(=O)C3=CC=CC=C32'}]
137,ochratoxin A,C025589,303-47-9,C1QB,713,mRNA,Rattus norvegicus,10116.0,ochratoxin A results in increased expression of C1QB mRNA,increases^expression,16251485,[{442530: 'C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)Cl'}]
138,Oxaliplatin,D000077150,,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Oxaliplatin co-treated with Topotecan] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,25729387,[{9887053: 'C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]'}]
139,Oxaliplatin,D000077150,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Oxaliplatin results in increased expression of C1QB mRNA,increases^expression,25729387,
140,Oxygen,D010100,7782-44-7,C1QB,713,mRNA,Mus musculus,10090.0,"[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with [Oxygen deficiency co-treated with Blood Glucose deficiency]] results in increased expression of C1QB mRNA",affects^cotreatment|increases^expression,19640911,[{977: 'O=O'}]
141,Oxygen,D010100,7782-44-7,C1QB,713,mRNA,Rattus norvegicus,10116.0,Oxygen results in increased expression of C1QB mRNA,increases^expression,22911455,
142,Ozone,D010126,10028-15-6,C1QB,713,mRNA,Mus musculus,10090.0,Ozone results in increased expression of C1QB mRNA,increases^expression,33026818,[{24823: '[O-][O+]=O'}]
143,Paclitaxel,D017239,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Paclitaxel results in increased expression of C1QB mRNA,increases^expression,18754875,[{36314: 'CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C'}]
144,Palm Oil,D000073878,,C1QB,713,mRNA,Mus musculus,10090.0,Palm Oil results in decreased expression of C1QB mRNA,decreases^expression,18042831,[{168010143: 'CCCC1=CC=C(C=C1)C2=CC(=C(C=C2)OC(=O)C3=CC=C(C=C3)OC(COC(=O)C=C)OC(=O)C=C)C=NNC4=NC5=CC=CC=C5S4.CC1=CC(=C(C=C1)OC(=O)C2=CC3=CC(=C(C=C3C=C2)OC(=O)C4=CC=C(C=C4)OCC(COCCCCOC(=O)C=C)OC(=O)CCOC(=O)C=C)C=NNC5=NC6=CC=CC=C6S5)C.CC1=C(C=CC(=C1)OC)OC(=O)C2=CC(=C(C=C2)OC(=O)C3=CC=C(C=C3)OCC(COCCCCOC(=O)C=C)OC(=O)CCOC(=O)C=C)C=NNC4=NC5=CC=CC=C5S4'}]
145,Particulate Matter,D052638,,C1QB,713,mRNA,Homo sapiens,9606.0,Particulate Matter results in increased expression of C1QB mRNA,increases^expression,24769257,[{9549209: 'CCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)O)O'}]
146,Particulate Matter,D052638,,C1QB,713,mRNA,Mus musculus,10090.0,Particulate Matter affects the expression of C1QB mRNA,affects^expression,32873817,
147,Particulate Matter,D052638,,C1QB,713,mRNA,Mus musculus,10090.0,"[Particulate Matter co-treated with Antigens, Dermatophagoides] results in increased expression of C1QB mRNA",affects^cotreatment|increases^expression,34051097,
148,perfluorooctane sulfonic acid,C076994,1763-23-1,C1QB,713,mRNA,Mus musculus,10090.0,[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,36331819,[{74483: 'C(C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F'}]
149,peroben,C008814,78371-63-8,C1QB,713,protein,Homo sapiens,9606.0,peroben results in increased activity of [C1QA protein binds to C1QB protein binds to C1QC protein],affects^binding|increases^activity,157301,[{192144: 'CCC1(C(=O)C=CNC1=O)CC.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2'}]
150,Phenobarbital,D010634,50-06-6,C1QB,713,mRNA,Mus musculus,10090.0,NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of C1QB mRNA],affects^reaction|decreases^expression,19482888,[{4763: 'CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2'}]
151,Phenobarbital,D010634,50-06-6,C1QB,713,mRNA,Mus musculus,10090.0,Phenobarbital results in decreased expression of C1QB mRNA,decreases^expression,19482888,
152,Phenobarbital,D010634,50-06-6,C1QB,713,mRNA,Rattus norvegicus,10116.0,Phenobarbital results in increased expression of C1QB mRNA,increases^expression,19162173,
153,pirinixic acid,C006253,50892-23-4,C1QB,713,mRNA,Mus musculus,10090.0,pirinixic acid results in decreased expression of C1QB mRNA,decreases^expression,17426115|23811191,[{5694: 'CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C'}]
154,polyhexamethyleneguanidine,C060540,31961-54-3,C1QB,713,mRNA,Rattus norvegicus,10116.0,polyhexamethyleneguanidine results in increased expression of C1QB mRNA,increases^expression,27989595|32080758,[{14771682: 'CCCCNC(=NCCCC)N'}]
155,polyhexamethyleneguanidine,C060540,31961-54-3,C1QB,713,protein,Rattus norvegicus,10116.0,polyhexamethyleneguanidine results in increased expression of C1QB protein,increases^expression,32080758,
156,Pravastatin,D017035,81093-37-0,C1QB,713,mRNA,Mus musculus,10090.0,Pravastatin results in decreased expression of C1QB mRNA,decreases^expression,27225895,[{54687: 'CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O'}]
157,Pravastatin,D017035,81093-37-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,Pravastatin results in decreased expression of C1QB mRNA,decreases^expression,27225895,
158,Pregnenolone Carbonitrile,D011285,1434-54-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,Pregnenolone Carbonitrile results in decreased expression of C1QB mRNA,decreases^expression,19162173,[{15032: 'CC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C#N'}]
159,propionaldehyde,C005556,123-38-6,C1QB,713,mRNA,Homo sapiens,9606.0,propionaldehyde results in decreased expression of C1QB mRNA,decreases^expression,26079696,[{527: 'CCC=O'}]
160,PTC-209,C586999,,C1QB,713,mRNA,Mus musculus,10090.0,[IGF1 protein co-treated with MM-589 co-treated with A-83-01 co-treated with PTC-209] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,31023824,[{1117196: 'CC1=C(N2C=CC=NC2=N1)C3=CSC(=N3)NC4=C(C=C(C=C4Br)OC)Br'}]
161,pyrachlostrobin,C513428,,C1QB,713,mRNA,Mus musculus,10090.0,pyrachlostrobin results in increased expression of C1QB mRNA,increases^expression,27029645,[{6422843: 'COC(=O)N(C1=CC=CC=C1COC2=NN(C=C2)C3=CC=C(C=C3)Cl)OC'}]
162,Raloxifene Hydrochloride,D020849,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Raloxifene Hydrochloride affects the expression of C1QB mRNA,affects^expression,16079270,[{54900: 'C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl'}]
163,Resveratrol,D000077185,,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Resveratrol co-treated with Streptozocin] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,25905778,[{445154: 'C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O'}]
164,Resveratrol,D000077185,,C1QB,713,mRNA,Rattus norvegicus,10116.0,Resveratrol results in increased expression of C1QB mRNA,increases^expression,25905778,
165,Rotenone,D012402,83-79-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,Rotenone results in increased expression of C1QB mRNA,increases^expression,28374803,[{6758: 'CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC'}]
166,Selenium,D012643,7782-49-2,C1QB,713,mRNA,Homo sapiens,9606.0,Selenium results in increased expression of C1QB mRNA,increases^expression,19244175,[{6326970: '[Se]'}]
167,Silicon Dioxide,D012822,7631-86-9,C1QB,713,mRNA,Mus musculus,10090.0,Silicon Dioxide results in decreased expression of C1QB mRNA,decreases^expression,23221170,[{24261: 'O=[Si]=O'}]
168,Silicon Dioxide,D012822,7631-86-9,C1QB,713,mRNA,Mus musculus,10090.0,Silicon Dioxide results in increased expression of C1QB mRNA,increases^expression,29341224,
169,sodium arsenate,C009277,,C1QB,713,mRNA,Danio rerio,7955.0,sodium arsenate results in decreased expression of C1QB mRNA,decreases^expression,23922661,[{47275: '[O-][As](=O)([O-])[O-].[Na+].[Na+].[Na+]'}]
170,Soman,D012999,96-64-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,Soman results in increased expression of C1QB mRNA,increases^expression,19281266,[{7305: 'CC(C(C)(C)C)OP(=O)(C)F'}]
171,Soot,D053260,,C1QB,713,mRNA,Mus musculus,10090.0,Soot results in increased expression of C1QB mRNA,increases^expression,26551751,[{5462310: '[C]'}]
172,Streptozocin,D013311,18883-66-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Resveratrol co-treated with Streptozocin] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,25905778,"[{29327: 'CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O'}, {2733335: 'CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O)CO)O)O)N=O'}, {5300: 'CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O'}, {6713972: 'CN(C(=O)NC1[C@@H]([C@@H](C(O[C@@H]1O)CO)O)O)N=O'}, {7067772: 'CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O)O)N=O'}, {134695375: 'CN(C(=O)N[C@@H]1[C@H](C(C(O[C@@H]1O)CO)O)O)N=O'}, {138403271: 'CN(C(=O)N[C@@H]1[C@H]([C@@H](C(OC1O)CO)O)O)N=O'}]"
173,Streptozocin,D013311,18883-66-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,Streptozocin results in increased expression of C1QB mRNA,increases^expression,16684804,
174,Streptozocin,D013311,18883-66-4,C1QB,713,mRNA,Rattus norvegicus,10116.0,vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of C1QB mRNA],decreases^reaction|increases^expression,16684804,
175,St. Thomas' Hospital cardioplegic solution,C041711,,C1QB,713,mRNA,Rattus norvegicus,10116.0,St. Thomas' Hospital cardioplegic solution results in decreased expression of C1QB mRNA,decreases^expression,16214533,
176,systhane,C446685,,C1QB,713,mRNA,Rattus norvegicus,10116.0,systhane results in decreased expression of C1QB mRNA,decreases^expression,32268158,[{6336: 'CCCCC(CN1C=NC=N1)(C#N)C2=CC=C(C=C2)Cl'}]
177,Tacrolimus,D016559,109581-93-3,C1QB,713,mRNA,Mus musculus,10090.0,Tacrolimus results in increased expression of C1QB mRNA,increases^expression,29362864,[{445643: 'C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC'}]
178,Tamoxifen,D013629,10540-29-1,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Bexarotene co-treated with Tamoxifen] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,17630414,[{2733526: 'CC/C(=C(\\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3'}]
179,Testosterone,D013739,58-22-0,C1QB,713,mRNA,Mus musculus,10090.0,"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of C1QB mRNA]",decreases^reaction|increases^expression,33848595,[{6013: 'C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C'}]
180,Testosterone,D013739,58-22-0,C1QB,713,mRNA,Mus musculus,10090.0,Testosterone deficiency results in increased expression of C1QB mRNA,increases^expression,33848595,
181,Testosterone,D013739,58-22-0,C1QB,713,mRNA,Rattus norvegicus,10116.0,[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,32741896,
182,Tetrachlorodibenzodioxin,D013749,1746-01-6,C1QB,713,mRNA,Mus musculus,10090.0,Tetrachlorodibenzodioxin affects the expression of C1QB mRNA,affects^expression,24680724|28922406,[{15625: 'C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl'}]
183,Tetrachlorodibenzodioxin,D013749,1746-01-6,C1QB,713,mRNA,Mus musculus,10090.0,[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,17942748,
184,Tetrachlorodibenzodioxin,D013749,1746-01-6,C1QB,713,mRNA,Mus musculus,10090.0,Tetrachlorodibenzodioxin results in decreased expression of C1QB mRNA,decreases^expression,19465110,
185,Tetrachlorodibenzodioxin,D013749,1746-01-6,C1QB,713,mRNA,Mus musculus,10090.0,Tetrachlorodibenzodioxin results in increased expression of C1QB mRNA,increases^expression,16960034,
186,Tetrachlorodibenzodioxin,D013749,1746-01-6,C1QB,713,mRNA,Rattus norvegicus,10116.0,Tetrachlorodibenzodioxin affects the expression of C1QB mRNA,affects^expression,34747641,
187,Tetrachlorodibenzodioxin,D013749,1746-01-6,C1QB,713,mRNA,Rattus norvegicus,10116.0,Tetrachlorodibenzodioxin results in increased expression of C1QB mRNA,increases^expression,21215274|22808131|32109520,
188,Tetradecanoylphorbol Acetate,D013755,16561-29-8,C1QB,713,mRNA,Oryctolagus cuniculus,9986.0,[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,25613284,[{27924: 'CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C'}]
189,Thioacetamide,D013853,62-55-5,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,28943392,[{2723949: 'CC(=S)N'}]
190,titanium dioxide,C009495,13463-67-7,C1QB,713,mRNA,Mus musculus,10090.0,[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QB mRNA,affects^cotreatment|decreases^expression,29950665,[{26042: 'O=[Ti]=O'}]
191,titanium dioxide,C009495,13463-67-7,C1QB,713,mRNA,Mus musculus,10090.0,titanium dioxide results in increased expression of C1QB mRNA,increases^expression,21259345|23557971,
192,Tobacco Smoke Pollution,D014028,,C1QB,713,mRNA,Mus musculus,10090.0,[APOE gene mutant form affects the susceptibility to Tobacco Smoke Pollution] which results in increased expression of C1QB mRNA,affects^response to substance|increases^expression,24096154,
193,Tobacco Smoke Pollution,D014028,,C1QB,713,mRNA,Mus musculus,10090.0,Tobacco Smoke Pollution affects the expression of C1QB mRNA,affects^expression,20133372,
194,Topotecan,D019772,123948-87-8,C1QB,713,mRNA,Rattus norvegicus,10116.0,[Oxaliplatin co-treated with Topotecan] results in increased expression of C1QB mRNA,affects^cotreatment|increases^expression,25729387,[{60700: 'CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O'}]
195,"Toxins, Biological",D014118,,C1QB,713,mRNA,Mus musculus,10090.0,"Toxins, Biological affects the expression of C1QB mRNA",affects^expression,19682533,
196,Trichloroethylene,D014241,79-01-6,C1QB,713,mRNA,Mus musculus,10090.0,Trichloroethylene results in decreased expression of C1QB mRNA,decreases^expression,19448997,[{6575: 'C(=C(Cl)Cl)Cl'}]
197,trimellitic anhydride,C015559,552-30-7,C1QB,713,mRNA,Mus musculus,10090.0,trimellitic anhydride results in increased expression of C1QB mRNA,increases^expression,16141432,[{11089: 'C1=CC2=C(C=C1C(=O)O)C(=O)OC2=O'}]
198,trimethyltin,C046488,1631-73-8,C1QB,713,mRNA,Mus musculus,10090.0,trimethyltin results in increased expression of C1QB mRNA,increases^expression,21435392|24002884,[{5358116: 'C[Sn](C)C'}]
199,Trinitrobenzenesulfonic Acid,D014302,2508-19-2,C1QB,713,mRNA,Mus musculus,10090.0,Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of C1QB mRNA],decreases^reaction|increases^expression,18200517,[{11045: 'C1=C(C=C(C(=C1[N+](=O)[O-])S(=O)(=O)O)[N+](=O)[O-])[N+](=O)[O-]'}]
200,Trinitrobenzenesulfonic Acid,D014302,2508-19-2,C1QB,713,mRNA,Mus musculus,10090.0,Trinitrobenzenesulfonic Acid results in increased expression of C1QB mRNA,increases^expression,17982090|18200517,
201,Troglitazone,D000077288,97322-87-7,C1QB,713,mRNA,Mus musculus,10090.0,Troglitazone results in increased expression of C1QB mRNA,increases^expression,28973697,[{5591: 'CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C'}]
202,vanadyl sulfate,C034028,27774-13-6,C1QB,713,mRNA,Rattus norvegicus,10116.0,vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of C1QB mRNA],decreases^reaction|increases^expression,16684804,[{34007: '[O-]S(=O)(=O)[O-].O=[V+2]'}]
203,Vancomycin,D014640,1404-90-6,C1QB,713,mRNA,Mus musculus,10090.0,Vancomycin results in decreased expression of C1QB mRNA,decreases^expression,18930951,[{14969: 'C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O'}]
204,vinclozolin,C025643,50471-44-8,C1QB,713,mRNA,Rattus norvegicus,10116.0,vinclozolin results in decreased expression of C1QB mRNA,decreases^expression,23034163,[{39676: 'CC1(C(=O)N(C(=O)O1)C2=CC(=CC(=C2)Cl)Cl)C=C'}]
205,vinylidene chloride,C029297,75-35-4,C1QB,713,mRNA,Mus musculus,10090.0,vinylidene chloride results in increased expression of C1QB mRNA,increases^expression,26682919,[{6366: 'C=C(Cl)Cl'}]
206,Zinc,D015032,7440-66-6,C1QB,713,protein,Homo sapiens,9606.0,C1QB protein binds to Zinc,affects^binding,23896426,[{23994: '[Zn]'}]
207,Zinc,D015032,7440-66-6,C1QB,713,mRNA,Homo sapiens,9606.0,Zinc deficiency results in increased expression of C1QB mRNA,increases^expression,22171008,
